Name,Empirical formula,CAS,SMILES,Canonical SMILES,"Mw, g*mol-1","CC50/IC50/EC50, mM","Statistics (95% CI, SEM, SD, RMSE, SE etc.)","Incubation time, h",Cell line,Method,Reference (author+year+journal),doi,Notes
(R)-1-butoxy-3-methyl-1-oxobutan-2-aminium 2-(4-isobutylphenyl)propanoate,C22H37NO4,,CC(C)[C@@H]([NH3+])C(OCCCC)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCCCOC(=O)[C@H]([NH3+])C(C)C,379.541,2.2659,0.10539 (SD),24,NIH/3T3,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-butoxy-3-methyl-1-oxobutan-2-aminium 2-(4-isobutylphenyl)propanoate,C22H37NO4,,CC(C)[C@@H]([NH3+])C(OCCCC)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCCCOC(=O)[C@H]([NH3+])C(C)C,379.541,1.34373,0.05269 (SD),24,HaCat,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-ethoxy-1-oxo-3-phenylpropan-2-aminium 2-(4-isobutylphenyl)propanoate,C24H33NO4,,O=C(OCC)[C@H]([NH3+])CC1=CC=CC=C1.CC(C([O-])=O)C2=CC=C(C=C2)CC(C)C,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCOC(=O)[C@H]([NH3+])Cc1ccccc1,399.531,1.57689,0.07509 (SD),24,NIH/3T3,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-ethoxy-1-oxo-3-phenylpropan-2-aminium 2-(4-isobutylphenyl)propanoate,C24H33NO4,,O=C(OCC)[C@H]([NH3+])CC1=CC=CC=C1.CC(C([O-])=O)C2=CC=C(C=C2)CC(C)C,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCOC(=O)[C@H]([NH3+])Cc1ccccc1,399.531,1.2765,0.05005 (SD),24,HaCat,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-ethoxy-3-methyl-1-oxobutan-2-aminium 2-(4-isobutylphenyl)propanoate,C20H33NO4,,CC(C)[C@@H]([NH3+])C(OCC)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCOC(=O)[C@H]([NH3+])C(C)C,351.487,3.64164,0.19915 (SD),24,NIH/3T3,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-ethoxy-3-methyl-1-oxobutan-2-aminium 2-(4-isobutylphenyl)propanoate,C20H33NO4,,CC(C)[C@@H]([NH3+])C(OCC)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCOC(=O)[C@H]([NH3+])C(C)C,351.487,1.28026,0.05690 (SD),24,HaCat,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-ethoxy-4-methyl-1-oxopentan-2-aminium 2-(4-isobutylphenyl)propanoate,C21H35NO4,,CC(C)C[C@@H]([NH3+])C(OCC)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCOC(=O)[C@H]([NH3+])CC(C)C,365.514,6.51145,0.38302 (SD),24,NIH/3T3,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-ethoxy-4-methyl-1-oxopentan-2-aminium 2-(4-isobutylphenyl)propanoate,C21H35NO4,,CC(C)C[C@@H]([NH3+])C(OCC)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCOC(=O)[C@H]([NH3+])CC(C)C,365.514,1.55946,0.08207 (SD),24,HaCat,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-isopropoxy-3-methyl-1-oxobutan-2-aminium 2-(4-isobutylphenyl)propanoate,C21H35NO4,,CC(C)[C@@H]([NH3+])C(OC(C)C)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CC(C)OC(=O)[C@H]([NH3+])C(C)C,365.514,2.57175,0.16415 (SD),24,NIH/3T3,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-isopropoxy-3-methyl-1-oxobutan-2-aminium 2-(4-isobutylphenyl)propanoate,C21H35NO4,,CC(C)[C@@H]([NH3+])C(OC(C)C)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CC(C)OC(=O)[C@H]([NH3+])C(C)C,365.514,1.25852,0.05471 (SD),24,HaCat,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-methoxy-1-oxo-3-phenylpropan-2-aminium 2-(4-isobutylphenyl)propanoate,C23H31NO4,,COC([C@H]([NH3+])CC1=CC=CC=C1)=O.CC(C([O-])=O)C2=CC=C(C=C2)CC(C)C,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.COC(=O)[C@H]([NH3+])Cc1ccccc1,385.504,1.24514,0.02594 (SD),24,NIH/3T3,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-methoxy-1-oxo-3-phenylpropan-2-aminium 2-(4-isobutylphenyl)propanoate,C23H31NO4,,COC([C@H]([NH3+])CC1=CC=CC=C1)=O.CC(C([O-])=O)C2=CC=C(C=C2)CC(C)C,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.COC(=O)[C@H]([NH3+])Cc1ccccc1,385.504,2.38651,0.12970 (SD),24,HaCat,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-oxo-3-phenyl-1-propoxypropan-2-aminium 2-(4-isobutylphenyl)propanoate,C25H35NO4,,O=C(OCCC)[C@H]([NH3+])CC1=CC=CC=C1.CC(C([O-])=O)C2=CC=C(C=C2)CC(C)C,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCCOC(=O)[C@H]([NH3+])Cc1ccccc1,413.558,1.42664,0.12090 (SD),24,NIH/3T3,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-1-oxo-3-phenyl-1-propoxypropan-2-aminium 2-(4-isobutylphenyl)propanoate,C25H35NO4,,O=C(OCCC)[C@H]([NH3+])CC1=CC=CC=C1.CC(C([O-])=O)C2=CC=C(C=C2)CC(C)C,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCCOC(=O)[C@H]([NH3+])Cc1ccccc1,413.558,1.7168,0.09672 (SD),24,HaCat,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-3-methyl-1-oxo-1-propoxybutan-2-aminium 2-(4-isobutylphenyl)propanoate,C21H35NO4,,CC(C)[C@@H]([NH3+])C(OCCC)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCCOC(=O)[C@H]([NH3+])C(C)C,365.514,3.00949,0.16415 (SD),24,NIH/3T3,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-3-methyl-1-oxo-1-propoxybutan-2-aminium 2-(4-isobutylphenyl)propanoate,C21H35NO4,,CC(C)[C@@H]([NH3+])C(OCCC)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCCOC(=O)[C@H]([NH3+])C(C)C,365.514,1.6689,0.08207 (SD),24,HaCat,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-4-methyl-1-oxo-1-propoxypentan-2-aminium 2-(4-isobutylphenyl)propanoate,C22H37NO4,,CC(C)C[C@@H]([NH3+])C(OCCC)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCCOC(=O)[C@H]([NH3+])CC(C)C,379.541,2.39764,0.13173 (SD),24,NIH/3T3,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(R)-4-methyl-1-oxo-1-propoxypentan-2-aminium 2-(4-isobutylphenyl)propanoate,C22H37NO4,,CC(C)C[C@@H]([NH3+])C(OCCC)=O.CC(C1=CC=C(CC(C)C)C=C1)C([O-])=O,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CCCOC(=O)[C@H]([NH3+])CC(C)C,379.541,2.00242,0.10539 (SD),24,HaCat,MTT,"Ossowicz-Rupniewska, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.119367,
(S)-1-butoxy-3-methyl-1-oxobutan-2-aminium 2-hydroxybenzoate,C16H25NO5,2920737-77-3,[O-]C(C1=C(C=CC=C1)O)=O.CC(C)[C@H]([NH3+])C(OCCCC)=O,CCCCOC(=O)[C@@H]([NH3+])C(C)C.O=C([O-])c1ccccc1O,311.378,0.992,0.029 (ND),24,NIH/3T3,NRU,"Klebeko, 2021, Molecules",10.3390/molecules27010216,CAS for neutral compound
(S)-1-butoxy-3-methyl-1-oxobutan-2-aminium 2-hydroxybenzoate,C16H25NO5,2920737-77-3,[O-]C(C1=C(C=CC=C1)O)=O.CC(C)[C@H]([NH3+])C(OCCCC)=O,CCCCOC(=O)[C@@H]([NH3+])C(C)C.O=C([O-])c1ccccc1O,311.378,1.927,0.642 (ND),24,HaCat,MTT,"Klebeko, 2021, Molecules",10.3390/molecules27010216,CAS for neutral compound
(S)-1-ethoxy-1-oxo-3-phenylpropan-2-aminium 2-hydroxybenzoate,C18H21NO5,,OC1=CC=CC=C1C([O-])=O.[NH3+][C@@H](CC2=CC=CC=C2)C(OCC)=O,CCOC(=O)[C@@H]([NH3+])Cc1ccccc1.O=C([O-])c1ccccc1O,331.368,3.205,0.045 (ND),24,NIH/3T3,NRU,"Klebeko, 2021, Molecules",10.3390/molecules27010216,
(S)-1-ethoxy-1-oxo-3-phenylpropan-2-aminium 2-hydroxybenzoate,C18H21NO5,,OC1=CC=CC=C1C([O-])=O.[NH3+][C@@H](CC2=CC=CC=C2)C(OCC)=O,CCOC(=O)[C@@H]([NH3+])Cc1ccccc1.O=C([O-])c1ccccc1O,331.368,6.639,0.453 (ND),24,HaCat,MTT,"Klebeko, 2021, Molecules",10.3390/molecules27010216,
(S)-1-ethoxy-3-methyl-1-oxobutan-2-aminium 2-hydroxybenzoate,C14H21NO5,2920737-74-0,OC1=CC=CC=C1C([O-])=O.CC(C)[C@H]([NH3+])C(OCC)=O,CCOC(=O)[C@@H]([NH3+])C(C)C.O=C([O-])c1ccccc1O,283.324,2.471,0.028 (ND),24,NIH/3T3,NRU,"Klebeko, 2021, Molecules",10.3390/molecules27010216,CAS for neutral compound
(S)-1-ethoxy-3-methyl-1-oxobutan-2-aminium 2-hydroxybenzoate,C14H21NO5,2920737-74-0,OC1=CC=CC=C1C([O-])=O.CC(C)[C@H]([NH3+])C(OCC)=O,CCOC(=O)[C@@H]([NH3+])C(C)C.O=C([O-])c1ccccc1O,283.324,2.118,0.035 (ND),24,HaCat,MTT,"Klebeko, 2021, Molecules",10.3390/molecules27010216,CAS for neutral compound
(S)-1-ethoxy-4-methyl-1-oxopentan-2-aminium 2-hydroxybenzoate,C15H23NO5,,[O-]C(C1=C(C=CC=C1)O)=O.CCOC([C@@H]([NH3+])CC(C)C)=O,CCOC(=O)[C@@H]([NH3+])CC(C)C.O=C([O-])c1ccccc1O,297.351,3.007,0.04 (ND),24,NIH/3T3,NRU,"Klebeko, 2021, Molecules",10.3390/molecules27010216,
(S)-1-ethoxy-4-methyl-1-oxopentan-2-aminium 2-hydroxybenzoate,C15H23NO5,,[O-]C(C1=C(C=CC=C1)O)=O.CCOC([C@@H]([NH3+])CC(C)C)=O,CCOC(=O)[C@@H]([NH3+])CC(C)C.O=C([O-])c1ccccc1O,297.351,2.69,0.404 (ND),24,HaCat,MTT,"Klebeko, 2021, Molecules",10.3390/molecules27010216,
(S)-1-isopropoxy-3-methyl-1-oxobutan-2-aminium 2-hydroxybenzoate,C15H23NO5,2920737-75-1,[O-]C(C1=C(C=CC=C1)O)=O.CC(C)[C@H]([NH3+])C(OC(C)C)=O,CC(C)OC(=O)[C@@H]([NH3+])C(C)C.O=C([O-])c1ccccc1O,297.351,2.213,0.024 (ND),24,NIH/3T3,NRU,"Klebeko, 2021, Molecules",10.3390/molecules27010216,CAS for neutral compound
(S)-1-isopropoxy-3-methyl-1-oxobutan-2-aminium 2-hydroxybenzoate,C15H23NO5,2920737-75-1,[O-]C(C1=C(C=CC=C1)O)=O.CC(C)[C@H]([NH3+])C(OC(C)C)=O,CC(C)OC(=O)[C@@H]([NH3+])C(C)C.O=C([O-])c1ccccc1O,297.351,3.027,0.168 (ND),24,HaCat,MTT,"Klebeko, 2021, Molecules",10.3390/molecules27010216,CAS for neutral compound
(S)-1-methoxy-1-oxo-3-phenylpropan-2-aminium 2-hydroxybenzoate,C17H19NO5,,OC1=CC=CC=C1C([O-])=O.COC([C@@H]([NH3+])CC2=CC=CC=C2)=O,COC(=O)[C@@H]([NH3+])Cc1ccccc1.O=C([O-])c1ccccc1O,317.341,3.123,0.032 (SD),24,NIH/3T3,NRU,"Klebeko, 2021, Molecules",10.3390/molecules27010216,
(S)-1-methoxy-1-oxo-3-phenylpropan-2-aminium 2-hydroxybenzoate,C17H19NO5,,OC1=CC=CC=C1C([O-])=O.COC([C@@H]([NH3+])CC2=CC=CC=C2)=O,COC(=O)[C@@H]([NH3+])Cc1ccccc1.O=C([O-])c1ccccc1O,317.341,4.097,0.63 (ND),24,HaCat,MTT,"Klebeko, 2021, Molecules",10.3390/molecules27010216,
(S)-1-methoxy-1-oxopropan-2-aminium tetrafluoroborate,C4H10BF4NO2,863889-71-8,C[C@H]([NH3+])C(OC)=O.F[B-](F)(F)F,COC(=O)[C@H](C)[NH3+].F[B-](F)(F)F,190.933,9.56,0.37 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
(S)-1-methoxy-3-methyl-1-oxobutan-2-aminium tetrafluoroborate,C6H14BF4NO2,1428647-27-1,COC([C@@H]([NH3+])C(C)C)=O.F[B-](F)(F)F,COC(=O)[C@@H]([NH3+])C(C)C.F[B-](F)(F)F,218.987,6.57,0.1 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
(S)-1-oxo-3-phenyl-1-propoxypropan-2-aminium 2-hydroxybenzoate,C19H23NO5,,OC1=CC=CC=C1C([O-])=O.[NH3+][C@H](C(OCCC)=O)CC2=CC=CC=C2,CCCOC(=O)[C@@H]([NH3+])Cc1ccccc1.O=C([O-])c1ccccc1O,345.395,1.917,0.026 (ND),24,NIH/3T3,NRU,"Klebeko, 2021, Molecules",10.3390/molecules27010216,
(S)-1-oxo-3-phenyl-1-propoxypropan-2-aminium 2-hydroxybenzoate,C19H23NO5,,OC1=CC=CC=C1C([O-])=O.[NH3+][C@H](C(OCCC)=O)CC2=CC=CC=C2,CCCOC(=O)[C@@H]([NH3+])Cc1ccccc1.O=C([O-])c1ccccc1O,345.395,1.882,0.29 (ND),24,HaCat,MTT,"Klebeko, 2021, Molecules",10.3390/molecules27010216,
"(S)-2-(ethoxycarbonyl)pyrrolidin-1-ium (S)-4-carboxy-4-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)butanoate",C27H35N9O7,,O=C([C@H]1[NH2+]CCC1)OCC.O=C([O-])CC[C@@H](C(O)=O)NC(C2=CC=C(N(CC3=NC4=C(N)N=C(N)N=C4N=C3)C)C=C2)=O,CCOC(=O)[C@@H]1CCC[NH2+]1.CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)O)cc1,597.633,0.0515,,24,B16F10,WST-1,"Moshikur, 2021, Int. J. Pharm.",10.1016/j.ijpharm.2021.121129,
(S)-2-(ethoxycarbonyl)pyrrolidin-1-ium 2-hydroxybenzoate,C14H19NO5,2231419-64-8,[O-]C(C1=C(C=CC=C1)O)=O.CCOC([C@H]2[NH2+]CCC2)=O,CCOC(=O)[C@@H]1CCC[NH2+]1.O=C([O-])c1ccccc1O,281.308,18.3,,24,L929,WST-1,"Moshikur, 2018, Int. J. Pharm.",10.1016/j.ijpharm.2018.05.021,"pH = 7.4, CAS for neutral compound"
(S)-2-(ethoxycarbonyl)pyrrolidin-1-ium 2-hydroxybenzoate,C14H19NO5,2231419-64-8,[O-]C(C1=C(C=CC=C1)O)=O.CCOC([C@H]2[NH2+]CCC2)=O,CCOC(=O)[C@@H]1CCC[NH2+]1.O=C([O-])c1ccccc1O,281.308,44.8,,24,HeLa,WST-1,"Moshikur, 2018, Int. J. Pharm.",10.1016/j.ijpharm.2018.05.021,"pH = 7.4, CAS for neutral compound"
(S)-2-(isobutoxycarbonyl)pyrrolidin-1-ium 2-hydroxybenzoate,C16H23NO5,,OC1=C(C([O-])=O)C=CC=C1.O=C([C@@H]2CCC[NH2+]2)OCC(C)C,CC(C)COC(=O)[C@@H]1CCC[NH2+]1.O=C([O-])c1ccccc1O,309.362,2.9,,24,L929,WST-1,"Moshikur, 2018, Int. J. Pharm.",10.1016/j.ijpharm.2018.05.021,pH = 7.4
(S)-2-(isobutoxycarbonyl)pyrrolidin-1-ium 2-hydroxybenzoate,C16H23NO5,,OC1=C(C([O-])=O)C=CC=C1.O=C([C@@H]2CCC[NH2+]2)OCC(C)C,CC(C)COC(=O)[C@@H]1CCC[NH2+]1.O=C([O-])c1ccccc1O,309.362,15.2,,24,HeLa,WST-1,"Moshikur, 2018, Int. J. Pharm.",10.1016/j.ijpharm.2018.05.021,pH = 7.4
(S)-2-(isopropoxycarbonyl)pyrrolidin-1-ium 2-hydroxybenzoate,C15H21NO5,,OC1=C(C([O-])=O)C=CC=C1.O=C([C@@H]2CCC[NH2+]2)OC(C)C,CC(C)OC(=O)[C@@H]1CCC[NH2+]1.O=C([O-])c1ccccc1O,295.335,6.5,,24,L929,WST-1,"Moshikur, 2018, Int. J. Pharm.",10.1016/j.ijpharm.2018.05.021,pH = 7.4
(S)-2-(isopropoxycarbonyl)pyrrolidin-1-ium 2-hydroxybenzoate,C15H21NO5,,OC1=C(C([O-])=O)C=CC=C1.O=C([C@@H]2CCC[NH2+]2)OC(C)C,CC(C)OC(=O)[C@@H]1CCC[NH2+]1.O=C([O-])c1ccccc1O,295.335,33.4,,24,HeLa,WST-1,"Moshikur, 2018, Int. J. Pharm.",10.1016/j.ijpharm.2018.05.021,pH = 7.4
(S)-2-(methoxycarbonyl)pyrrolidin-1-ium 2-hydroxybenzoate,C13H17NO5,,OC1=C(C([O-])=O)C=CC=C1.O=C([C@@H]2CCC[NH2+]2)OC,COC(=O)[C@@H]1CCC[NH2+]1.O=C([O-])c1ccccc1O,267.281,17.6,,24,L929,WST-1,"Moshikur, 2018, Int. J. Pharm.",10.1016/j.ijpharm.2018.05.021,pH = 7.4
(S)-2-(methoxycarbonyl)pyrrolidin-1-ium 2-hydroxybenzoate,C13H17NO5,,OC1=C(C([O-])=O)C=CC=C1.O=C([C@@H]2CCC[NH2+]2)OC,COC(=O)[C@@H]1CCC[NH2+]1.O=C([O-])c1ccccc1O,267.281,38.9,,24,HeLa,WST-1,"Moshikur, 2018, Int. J. Pharm.",10.1016/j.ijpharm.2018.05.021,pH = 7.4
(S)-3-methyl-1-oxo-1-propoxybutan-2-aminium 2-hydroxybenzoate,C15H23NO5,2920737-76-2,OC1=CC=CC=C1C([O-])=O.CC([C@@H](C(OCCC)=O)[NH3+])C,CCCOC(=O)[C@@H]([NH3+])C(C)C.O=C([O-])c1ccccc1O,297.351,4.406,0.057 (ND),24,NIH/3T3,NRU,"Klebeko, 2021, Molecules",10.3390/molecules27010216,CAS for neutral compound
(S)-3-methyl-1-oxo-1-propoxybutan-2-aminium 2-hydroxybenzoate,C15H23NO5,2920737-76-2,OC1=CC=CC=C1C([O-])=O.CC([C@@H](C(OCCC)=O)[NH3+])C,CCCOC(=O)[C@@H]([NH3+])C(C)C.O=C([O-])c1ccccc1O,297.351,1.682,0.168 (ND),24,HaCat,MTT,"Klebeko, 2021, Molecules",10.3390/molecules27010216,CAS for neutral compound
1-(2-(4-nitrophenyl)-2-oxoethyl)pyridazin-1-ium bromide,C12H10BrN3O3,25357-63-5,[Br-].O=C(C1=CC=C(C=C1)N(=O)=O)C[N+]2=NC=CC=C2,O=C(C[n+]1ccccn1)c1ccc([N+](=O)[O-])cc1.[Br-],324.134,30.0,,?,HCT-116,HCT/MTT,"Messali, 2015, S. Afr. J. Chem.",10.17159/0379-4350/2015/v68a30,
1-(2-(4-nitrophenyl)-2-oxoethyl)pyridazin-1-ium bromide,C12H10BrN3O3,25357-63-5,[Br-].O=C(C1=CC=C(C=C1)N(=O)=O)C[N+]2=NC=CC=C2,O=C(C[n+]1ccccn1)c1ccc([N+](=O)[O-])cc1.[Br-],324.134,48.0,,?,HepG2,HCT/MTT,"Messali, 2015, S. Afr. J. Chem.",10.17159/0379-4350/2015/v68a30,
1-(2-(4-nitrophenyl)-2-oxoethyl)pyridazin-1-ium bromide,C12H10BrN3O3,25357-63-5,[Br-].O=C(C1=CC=C(C=C1)N(=O)=O)C[N+]2=NC=CC=C2,O=C(C[n+]1ccccn1)c1ccc([N+](=O)[O-])cc1.[Br-],324.134,51.0,,?,MCF-7,HCT/MTT,"Messali, 2015, S. Afr. J. Chem.",10.17159/0379-4350/2015/v68a30,
1-(2-ethoxy-2-oxoethyl)pyridazin-1-ium chloride,C8H11ClN2O2,1878991-62-8,[Cl-].O=C(OCC)C[N+]1=NC=CC=C1,CCOC(=O)C[n+]1ccccn1.[Cl-],202.641,97.0,,?,HCT-116,HCT/MTT,"Messali, 2015, S. Afr. J. Chem.",10.17159/0379-4350/2015/v68a30,The exact assay and exposure time are unclear.
1-(2-ethoxy-2-oxoethyl)pyridazin-1-ium chloride,C8H11ClN2O2,1878991-62-8,[Cl-].O=C(OCC)C[N+]1=NC=CC=C1,CCOC(=O)C[n+]1ccccn1.[Cl-],202.641,85.0,,?,HepG2,HCT/MTT,"Messali, 2015, S. Afr. J. Chem.",10.17159/0379-4350/2015/v68a30,
1-(2-ethoxy-2-oxoethyl)pyridazin-1-ium chloride,C8H11ClN2O2,1878991-62-8,[Cl-].O=C(OCC)C[N+]1=NC=CC=C1,CCOC(=O)C[n+]1ccccn1.[Cl-],202.641,140.0,,?,MCF-7,HCT/MTT,"Messali, 2015, S. Afr. J. Chem.",10.17159/0379-4350/2015/v68a30,
1-(6-methoxy-6-oxohexyl)pyridazin-1-ium bromide,C11H17BrN2O2,1878991-64-0,[Br-].O=C(OC)CCCCC[N+]1=NC=CC=C1,COC(=O)CCCCC[n+]1ccccn1.[Br-],289.173,120.0,,?,HCT-116,HCT/MTT,"Messali, 2015, S. Afr. J. Chem.",10.17159/0379-4350/2015/v68a30,
1-(6-methoxy-6-oxohexyl)pyridazin-1-ium bromide,C11H17BrN2O2,1878991-64-0,[Br-].O=C(OC)CCCCC[N+]1=NC=CC=C1,COC(=O)CCCCC[n+]1ccccn1.[Br-],289.173,110.0,,?,HepG2,HCT/MTT,"Messali, 2015, S. Afr. J. Chem.",10.17159/0379-4350/2015/v68a30,
1-(6-methoxy-6-oxohexyl)pyridazin-1-ium bromide,C11H17BrN2O2,1878991-64-0,[Br-].O=C(OC)CCCCC[N+]1=NC=CC=C1,COC(=O)CCCCC[n+]1ccccn1.[Br-],289.173,100.0,,?,MCF-7,HCT/MTT,"Messali, 2015, S. Afr. J. Chem.",10.17159/0379-4350/2015/v68a30,
"1,4-diethoxy-1,4-dioxobutan-2-aminium (S)-4-carboxy-4-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)butanoate",C28H37N9O9,,[NH3+]C(CC(OCC)=O)C(OCC)=O.O=C([O-])CC[C@@H](C(O)=O)NC(C1=CC=C(N(CC2=NC3=C(N)N=C(N)N=C3N=C2)C)C=C1)=O,CCOC(=O)CC([NH3+])C(=O)OCC.CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)[O-])C(=O)O)cc1,643.658,0.0525,,24,B16F10,WST-1,"Moshikur, 2021, Int. J. Pharm.",10.1016/j.ijpharm.2021.121129,
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium acetate",C9H16N2O2,2413981-39-0,O=C([O-])C.N1C2=[N+](CCC1)CCC2,C1CNC2=[N+](C1)CCC2.CC(=O)[O-],184.239,69.0,11 (ND),24,HCE,AlamarBlue,"Ruokonen, 2018, Chem. Eur. J.",10.1002/chem.201704924,
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium chloride",C7H13ClN2,83548-28-1,C12=NCCC[NH+]1CCC2.[Cl-],C1CN=C2CCC[NH+]2C1.[Cl-],160.648,3.8e-05,0.0000053 (ND),24,GF,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,"GF, human gingival fibroblasts. CAS for neutral compound"
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium chloride",C7H13ClN2,83548-28-1,C12=NCCC[NH+]1CCC2.[Cl-],C1CN=C2CCC[NH+]2C1.[Cl-],160.648,0.000278,0.000019 (ND),24,T-47D,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,CAS for neutral compound
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium chloride",C7H13ClN2,83548-28-1,C12=NCCC[NH+]1CCC2.[Cl-],C1CN=C2CCC[NH+]2C1.[Cl-],160.648,0.00913,0.00103 (ND),24,A549,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,CAS for neutral compound
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium chloride",C7H13ClN2,83548-28-1,C12=NCCC[NH+]1CCC2.[Cl-],C1CN=C2CCC[NH+]2C1.[Cl-],160.648,9.79e-08,0.0000000176 (ND),24,MG63,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,CAS for neutral compound
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate",C11H25N3O7P2,,O=P(C(O)(P(O)(O)=O)CCCN)([O-])O.C12=[NH+]CCCN1CCC2,C1C[NH+]=C2CCCN2C1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,373.283,0.072,0.0055 (ND),24,GF,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,"GF, human gingival fibroblasts."
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate",C11H25N3O7P2,,O=P(C(O)(P(O)(O)=O)CCCN)([O-])O.C12=[NH+]CCCN1CCC2,C1C[NH+]=C2CCCN2C1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,373.283,0.255,0.034 (ND),72,GF,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,"GF, human gingival fibroblasts."
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate",C11H25N3O7P2,,O=P(C(O)(P(O)(O)=O)CCCN)([O-])O.C12=[NH+]CCCN1CCC2,C1C[NH+]=C2CCCN2C1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,373.283,6.14,0.87 (ND),24,A549,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,
"2,3,4,6,7,8-hexahydro-1H-pyrrolo[1,2-a]pyrimidin-5-ium hydrogen (4-amino-1-hydroxy-1-phosphonobutyl)phosphonate",C11H25N3O7P2,,O=P(C(O)(P(O)(O)=O)CCCN)([O-])O.C12=[NH+]CCCN1CCC2,C1C[NH+]=C2CCCN2C1.NCCCC(O)(P(=O)([O-])O)P(=O)(O)O,373.283,0.99,0.07 (ND),72,A549,MTT,"Teixeira, 2020, Pharmaceutics",10.3390/pharmaceutics12030293,
2-methoxy-2-oxoethan-1-aminium tetrafluoroborate,C3H8BF4NO2,1108210-81-6 ,O=C(C[NH3+])OC.F[B-](F)(F)F,COC(=O)C[NH3+].F[B-](F)(F)F,176.906,9.94,0.6 (SEM),24,NIH/3T3,MTS,"Egorova, 2015, Toxicol. Res.",10.1039/c4tx00079j,
"4-((6-chloro-2-methoxyacridin-9-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C53H78ClN3O4,2280802-35-7,CC[NH+](CC)CCCC(C)NC1=C(C=CC(Cl)=C2)C2=NC3=C1C=C(OC)C=C3.[O-]C([C@]45[C@@]([C@@H](CC5)C(C)=C)([H])[C@]6([H])[C@@](CC4)([C@]7([C@]([C@@]8([C@@](C(C)([C@H](CC8)O)C)([H])CC7)C)([H])CC6)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,856.677,0.013,0.001 (SD),24,HFF-1,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-chloro-2-methoxyacridin-9-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C53H78ClN3O4,2280802-35-7,CC[NH+](CC)CCCC(C)NC1=C(C=CC(Cl)=C2)C2=NC3=C1C=C(OC)C=C3.[O-]C([C@]45[C@@]([C@@H](CC5)C(C)=C)([H])[C@]6([H])[C@@](CC4)([C@]7([C@]([C@@]8([C@@](C(C)([C@H](CC8)O)C)([H])CC7)C)([H])CC6)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,856.677,0.016,0.001 (SD),24,RKO,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-chloro-2-methoxyacridin-9-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C53H78ClN3O4,2280802-35-7,CC[NH+](CC)CCCC(C)NC1=C(C=CC(Cl)=C2)C2=NC3=C1C=C(OC)C=C3.[O-]C([C@]45[C@@]([C@@H](CC5)C(C)=C)([H])[C@]6([H])[C@@](CC4)([C@]7([C@]([C@@]8([C@@](C(C)([C@H](CC8)O)C)([H])CC7)C)([H])CC6)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,856.677,0.013,0.001 (SD),24,T-47D,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-chloro-2-methoxyacridin-9-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C53H78ClN3O4,2280802-35-7,CC[NH+](CC)CCCC(C)NC1=C(C=CC(Cl)=C2)C2=NC3=C1C=C(OC)C=C3.[O-]C([C@]45[C@@]([C@@H](CC5)C(C)=C)([H])[C@]6([H])[C@@](CC4)([C@]7([C@]([C@@]8([C@@](C(C)([C@H](CC8)O)C)([H])CC7)C)([H])CC6)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,856.677,0.016,0.001 (SD),24,MG63,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-chloro-2-methoxyacridin-9-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C53H78ClN3O4,2280802-35-7,CC[NH+](CC)CCCC(C)NC1=C(C=CC(Cl)=C2)C2=NC3=C1C=C(OC)C=C3.[O-]C([C@]45[C@@]([C@@H](CC5)C(C)=C)([H])[C@]6([H])[C@@](CC4)([C@]7([C@]([C@@]8([C@@](C(C)([C@H](CC8)O)C)([H])CC7)C)([H])CC6)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,856.677,0.011,0.001 (SD),72,T-47D,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-chloro-2-methoxyacridin-9-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C53H78ClN3O4,2280802-35-7,CC[NH+](CC)CCCC(C)NC1=C(C=CC(Cl)=C2)C2=NC3=C1C=C(OC)C=C3.[O-]C([C@]45[C@@]([C@@H](CC5)C(C)=C)([H])[C@]6([H])[C@@](CC4)([C@]7([C@]([C@@]8([C@@](C(C)([C@H](CC8)O)C)([H])CC7)C)([H])CC6)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,856.677,0.0053,0.0009 (SD),72,MG63,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-chloro-2-methoxyacridin-9-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C53H78ClN3O4,2280802-35-7,CC[NH+](CC)CCCC(C)NC1=C(C=CC(Cl)=C2)C2=NC3=C1C=C(OC)C=C3.[O-]C([C@]45[C@@]([C@@H](CC5)C(C)=C)([H])[C@]6([H])[C@@](CC4)([C@]7([C@]([C@@]8([C@@](C(C)([C@H](CC8)O)C)([H])CC7)C)([H])CC6)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12,856.677,0.0041,0.0001 (SD),72,HepG2,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.012,0.001 (SD),24,HFF-1,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.013,0.001 (SD),24,RKO,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.013,0.001 (SD),24,T-47D,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.013,0.001 (SD),24,MG63,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.013,0.001 (SD),24,A549,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.014,0.001 (SD),24,HepG2,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.011,0.001 (SD),72,HFF-1,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.013,0.001 (SD),72,RKO,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.01106,0.0009 (SD),72,T-47D,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.006,0.001 (SD),72,MG63,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.01,0.001 (SD),72,A549,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((6-methoxyquinolin-8-yl)amino)pentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C45H69N3O4,2280802-32-4,[NH3+]CCCC(C)NC1=CC(OC)=CC2=C1N=CC=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.COc1cc(NC(C)CCC[NH3+])c2ncccc2c1,716.064,0.013,0.0009 (SD),72,HepG2,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C48H74ClN3O3,2280802-33-5,CC[NH+](CC)CCCC(C)NC1=CC=NC2=C1C=CC(Cl)=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,776.591,0.011,0.001 (SD),24,HFF-1,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C48H74ClN3O3,2280802-33-5,CC[NH+](CC)CCCC(C)NC1=CC=NC2=C1C=CC(Cl)=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,776.591,0.014,0.001 (SD),24,RKO,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C48H74ClN3O3,2280802-33-5,CC[NH+](CC)CCCC(C)NC1=CC=NC2=C1C=CC(Cl)=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,776.591,0.018,0.001 (SD),24,T-47D,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C48H74ClN3O3,2280802-33-5,CC[NH+](CC)CCCC(C)NC1=CC=NC2=C1C=CC(Cl)=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,776.591,0.018,0.001 (SD),24,MG63,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C48H74ClN3O3,2280802-33-5,CC[NH+](CC)CCCC(C)NC1=CC=NC2=C1C=CC(Cl)=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,776.591,0.016,0.001 (SD),24,A549,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C48H74ClN3O3,2280802-33-5,CC[NH+](CC)CCCC(C)NC1=CC=NC2=C1C=CC(Cl)=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,776.591,0.014,0.001 (SD),24,HepG2,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C48H74ClN3O3,2280802-33-5,CC[NH+](CC)CCCC(C)NC1=CC=NC2=C1C=CC(Cl)=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,776.591,0.012,0.001 (SD),72,HFF-1,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C48H74ClN3O3,2280802-33-5,CC[NH+](CC)CCCC(C)NC1=CC=NC2=C1C=CC(Cl)=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,776.591,0.015,0.001 (SD),72,RKO,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C48H74ClN3O3,2280802-33-5,CC[NH+](CC)CCCC(C)NC1=CC=NC2=C1C=CC(Cl)=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,776.591,0.015,0.001 (SD),72,T-47D,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C48H74ClN3O3,2280802-33-5,CC[NH+](CC)CCCC(C)NC1=CC=NC2=C1C=CC(Cl)=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,776.591,0.0101,0.0009 (SD),72,A549,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
"4-((7-chloroquinolin-4-yl)amino)-N,N-diethylpentan-1-aminium (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylate",C48H74ClN3O3,2280802-33-5,CC[NH+](CC)CCCC(C)NC1=CC=NC2=C1C=CC(Cl)=C2.[O-]C([C@]34[C@@]([C@@H](CC4)C(C)=C)([H])[C@]5([H])[C@@](CC3)([C@]6([C@]([C@@]7([C@@](C(C)([C@H](CC7)O)C)([H])CC6)C)([H])CC5)C)C)=O,C=C(C)[C@@H]1CC[C@]2(C(=O)[O-])CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CC[NH+](CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,776.591,0.0123,0.0009 (SD),72,HepG2,MTT,"Silva, 2019, ACS Omega",10.1021/acsomega.8b03691,CAS for neutral compound
5a chloride,C15H18Cl2MnN5O4S,,CN1C=C[N+](CC2=CC=C3C(/C=N/N4C(S[Mn](Cl)O3)N=CC4=O)=C2)=C1.[Cl-].O.O,Cn1cc[n+](Cc2ccc3c(c2)/C=N/N2C(=O)C=NC2S[Mn](Cl)O3)c1.O.O.[Cl-],490.251,0.00695,0.00107 (SD),48,MCF-7,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
5a chloride,C15H18Cl2MnN5O4S,,CN1C=C[N+](CC2=CC=C3C(/C=N/N4C(S[Mn](Cl)O3)N=CC4=O)=C2)=C1.[Cl-].O.O,Cn1cc[n+](Cc2ccc3c(c2)/C=N/N2C(=O)C=NC2S[Mn](Cl)O3)c1.O.O.[Cl-],490.251,0.13318,0.00275 (SD),48,HDFa,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
5b tetrafluoroborate,C15H18BClF4MnN5O4S,,CN1C=C[N+](CC2=CC=C3C(/C=N/N4C(N=CC4=O)S[Mn](O3)Cl)=C2)=C1.F[B-](F)(F)F.O.O,Cn1cc[n+](Cc2ccc3c(c2)/C=N/N2C(=O)C=NC2S[Mn](Cl)O3)c1.F[B-](F)(F)F.O.O,541.602,0.00283,0.00085 (SD),48,MCF-7,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
5b tetrafluoroborate,C15H18BClF4MnN5O4S,,CN1C=C[N+](CC2=CC=C3C(/C=N/N4C(N=CC4=O)S[Mn](O3)Cl)=C2)=C1.F[B-](F)(F)F.O.O,Cn1cc[n+](Cc2ccc3c(c2)/C=N/N2C(=O)C=NC2S[Mn](Cl)O3)c1.F[B-](F)(F)F.O.O,541.602,0.08505,0.00355 (SD),48,HDFa,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
6a chloride,C15H20Cl2FeN5O5S,,CN1C=C[N+](CC2=CC=C3C(/C=N/N4C(S[Fe](Cl)O3)N=CC4=O)=C2)=C1.[Cl-].O.O.O,Cn1cc[n+](Cc2ccc3c(c2)/C=N/N2C(=O)C=NC2S[Fe](Cl)O3)c1.O.O.O.[Cl-],509.173,0.00581,0.00125 (SD),48,MCF-7,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
6a chloride,C15H20Cl2FeN5O5S,,CN1C=C[N+](CC2=CC=C3C(/C=N/N4C(S[Fe](Cl)O3)N=CC4=O)=C2)=C1.[Cl-].O.O.O,Cn1cc[n+](Cc2ccc3c(c2)/C=N/N2C(=O)C=NC2S[Fe](Cl)O3)c1.O.O.O.[Cl-],509.173,0.11418,0.00315 (SD),48,HDFa,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
6b tetrafluoroborate,C15H20BClF4FeN5O5S,,CN1C=C[N+](CC2=CC=C3C(/C=N/N4C(S[Fe](Cl)O3)N=CC4=O)=C2)=C1.F[B-](F)(F)F.O.O.O,Cn1cc[n+](Cc2ccc3c(c2)/C=N/N2C(=O)C=NC2S[Fe](Cl)O3)c1.F[B-](F)(F)F.O.O.O,560.524,0.00198,0.00056 (SD),48,MCF-7,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
6b tetrafluoroborate,C15H20BClF4FeN5O5S,,CN1C=C[N+](CC2=CC=C3C(/C=N/N4C(S[Fe](Cl)O3)N=CC4=O)=C2)=C1.F[B-](F)(F)F.O.O.O,Cn1cc[n+](Cc2ccc3c(c2)/C=N/N2C(=O)C=NC2S[Fe](Cl)O3)c1.F[B-](F)(F)F.O.O.O,560.524,0.06916,0.00209 (SD),48,HDFa,MTT,"Abu Ali, 2023, Inorg. Chim. Acta",10.1016/j.ica.2023.121460,
"9-(2-(dodecanoyloxy)ethyl)-1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-9-ium bromide",C22H37BrN4O4,,O=C1N(C)C(N(C)C2=C1N(C)C=[N+]2CCOC(CCCCCCCCCCC)=O)=O.[Br-],CCCCCCCCCCCC(=O)OCC[n+]1cn(C)c2c(=O)n(C)c(=O)n(C)c21.[Br-],501.466,0.26567,,48,A549,MTT,"Arif, 2022, ChemistrySelect",10.1002/slct.202202689,
"9-(2-(hexadecanoyloxy)ethyl)-1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-9-ium bromide",C26H45BrN4O4,,O=C1N(C)C(N(C)C2=C1N(C)C=[N+]2CCOC(CCCCCCCCCCCCCCC)=O)=O.[Br-],CCCCCCCCCCCCCCCC(=O)OCC[n+]1cn(C)c2c(=O)n(C)c(=O)n(C)c21.[Br-],557.574,0.18421,,48,A549,MTT,"Arif, 2022, ChemistrySelect",10.1002/slct.202202689,
"9-(2-(tetradecanoyloxy)ethyl)-1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-9-ium bromide",C24H41BrN4O4,,O=C1N(C)C(N(C)C2=C1N(C)C=[N+]2CCOC(CCCCCCCCCCCCC)=O)=O.[Br-],CCCCCCCCCCCCCC(=O)OCC[n+]1cn(C)c2c(=O)n(C)c(=O)n(C)c21.[Br-],529.52,0.23342,,48,A549,MTT,"Arif, 2022, ChemistrySelect",10.1002/slct.202202689,
diethyl(methyl)sulfonium bis((trifluoromethyl)sulfonyl)imide,C7H13F6NO4S3,792188-85-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.[S+](C)(CC)CC,CC[S+](C)CC.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,385.373,2.59,2.32-2.86 (CI),24,Jurkat,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
diethyl(methyl)sulfonium bis((trifluoromethyl)sulfonyl)imide,C7H13F6NO4S3,792188-85-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.[S+](C)(CC)CC,CC[S+](C)CC.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,385.373,2.33,2.10-2.56 (CI),24,U937,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
diethyl(methyl)sulfonium bis((trifluoromethyl)sulfonyl)imide,C7H13F6NO4S3,792188-85-3,O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F.[S+](C)(CC)CC,CC[S+](C)CC.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,385.373,3.89,3.54-4.24 (CI),24,K562,Flow cytometry (7AAD),"Dzhemileva, 2024, Chemosphere",10.1016/j.chemosphere.2024.142964,
"dioctyl((4,5,7-trimethoxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)methyl)sulfonium tetrafluoroborate",C34H49BF4O5S,1809097-89-9,O=C1C2=C(C(C3=CC(OC)=CC(OC)=C31)=O)C=C(C=C2OC)C[S+](CCCCCCCC)CCCCCCCC.F[B-](F)(F)F,CCCCCCCC[S+](CCCCCCCC)Cc1cc(OC)c2c(c1)C(=O)c1cc(OC)cc(OC)c1C2=O.F[B-](F)(F)F,656.632,0.01158,0.00043 (ND),24,HepG2,MTT,"Yang, 2015, Chem. Biol. Drug Des.",10.1111/cbdd.12612,
"dioctyl((4,5,7-trimethoxy-9,10-dioxo-9,10-dihydroanthracen-2-yl)methyl)sulfonium tetrafluoroborate",C34H49BF4O5S,1809097-89-9,O=C1C2=C(C(C3=CC(OC)=CC(OC)=C31)=O)C=C(C=C2OC)C[S+](CCCCCCCC)CCCCCCCC.F[B-](F)(F)F,CCCCCCCC[S+](CCCCCCCC)Cc1cc(OC)c2c(c1)C(=O)c1cc(OC)cc(OC)c1C2=O.F[B-](F)(F)F,656.632,0.01339,0.00038 (ND),24,HELF,MTT,"Yang, 2015, Chem. Biol. Drug Des.",10.1111/cbdd.12612,
Metformin 2-(4-isobutylphenyl)propanoate,C17H29N5O2,,NC([NH2+]C(N(C)C)=N)=N.O=C([O-])C(C1=CC=C(C=C1)CC(C)C)C,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CN(C)C(=N)[NH2+]C(=N)N,335.452,0.157,,3,DLA,Trypan blue,"Safna Hussan, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120046,
Metformin 2-(4-isobutylphenyl)propanoate,C17H29N5O2,,NC([NH2+]C(N(C)C)=N)=N.O=C([O-])C(C1=CC=C(C=C1)CC(C)C)C,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CN(C)C(=N)[NH2+]C(=N)N,335.452,0.116,,3,Ehrlich-Lettre ascites strain E,Trypan blue,"Safna Hussan, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120046,
Metformin 2-(4-isobutylphenyl)propanoate,C17H29N5O2,,NC([NH2+]C(N(C)C)=N)=N.O=C([O-])C(C1=CC=C(C=C1)CC(C)C)C,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CN(C)C(=N)[NH2+]C(=N)N,335.452,0.552,,48,HCT-116,MTT,"Safna Hussan, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120046,
Metformin 2-(4-isobutylphenyl)propanoate,C17H29N5O2,,NC([NH2+]C(N(C)C)=N)=N.O=C([O-])C(C1=CC=C(C=C1)CC(C)C)C,CC(C)Cc1ccc(C(C)C(=O)[O-])cc1.CN(C)C(=N)[NH2+]C(=N)N,335.452,1.148,,48,MCF-7,MTT,"Safna Hussan, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120046,CAS for neutral compound
Metformin chloride,C4H12ClN5,1115-70-4,N=C([NH2+]C(N(C)C)=N)N.[Cl-],CN(C)C(=N)[NH2+]C(=N)N.[Cl-],165.628,0.02822,0.00283 (SD),24,HaCat,MTT,"Hong, 2022, Pharm. Res.",10.1007/s11095-022-03394-9,CAS for neutral compound
Metformin chloride,C4H12ClN5,1115-70-4,N=C([NH2+]C(N(C)C)=N)N.[Cl-],CN(C)C(=N)[NH2+]C(=N)N.[Cl-],165.628,0.389,,3,DLA,Trypan blue,"Safna Hussan, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120046,CAS for neutral compound
Metformin chloride,C4H12ClN5,1115-70-4,N=C([NH2+]C(N(C)C)=N)N.[Cl-],CN(C)C(=N)[NH2+]C(=N)N.[Cl-],165.628,0.0875,,3,Ehrlich-Lettre ascites strain E,Trypan blue,"Safna Hussan, 2022, J. Mol. Liq.",10.1016/j.molliq.2022.120046,CAS for neutral compound
Metformin dihexylsulfosuccinate,C20H41N5O7S,2588306-72-1,NC([NH2+]C(N(C)C)=N)=N.CCCCCCOC(CC(S(=O)([O-])=O)C(OCCCCCC)=O)=O,CCCCCCOC(=O)CC(C(=O)OCCCCCC)S(=O)(=O)[O-].CN(C)C(=N)[NH2+]C(=N)N,495.643,0.00062,0.00009 (SD),24,HaCat,MTT,"Hong, 2022, Pharm. Res.",10.1007/s11095-022-03394-9,CAS for neutral compound
Metformin docusate,C24H49N5O7S,1644550-89-9,NC([NH2+]C(N(C)C)=N)=N.CCCCC(CC)COC(CC(S(=O)([O-])=O)C(OCC(CC)CCCC)=O)=O,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].CN(C)C(=N)[NH2+]C(=N)N,551.751,1e-05,,24,HaCat,MTT,"Hong, 2022, Pharm. Res.",10.1007/s11095-022-03394-9,CAS for neutral compound
Metformin sulfacetamide ,C12H21N7O3S,2588306-78-7,NC([NH2+]C(N(C)C)=N)=N.NC1=CC=C(S(=O)([N-]C(C)=O)=O)C=C1,CC(=O)[N-]S(=O)(=O)c1ccc(N)cc1.CN(C)C(=N)[NH2+]C(=N)N,343.413,0.02489,0.00316 (SD),24,HaCat,MTT,"Hong, 2022, Pharm. Res.",10.1007/s11095-022-03394-9,CAS for neutral compound
"Potassium N,N,N-tributylammonio-undecahydro-closo-dodecaborate",C12H27*KN,1033467-02-5,CCCC[N+](CCCC)([1*-2])CCCC.[K+],[1*-2][N+](CCCC)(CCCC)CCCC.[K+],365.26,0.31,,24,V79,WST-1,"Schaffran, 2009, Green Chem.",10.1039/b906165g,CAS for neutral compound. SMILES from SciFinder - CCCC[N](B1234[BH]567[BH]189[BH]2%10%11[BH]3%12%13[BH]54%14[BH]6%15%16[BH]87%17[BH]9%10%18[BH]%17%15%19[BH]%14%12%16[BH]%18%11%13%19)(CCCC)CCCC.[K+]
"Potassium N,N,N-triethylammonio-undecahydro-closo-dodecaborate",C6H15*KN,1033466-92-0,CC[N+](CC)([1*-2])CC.[K+],[1*-2][N+](CC)(CC)CC.[K+],281.1,1.66,,24,V79,WST-1,"Schaffran, 2009, Green Chem.",10.1039/b906165g,CAS for neutral compound. SMILES from SciFinder - CC[N](CC)(B1234[BH]567[BH]189[BH]2%10%11[BH]3%12%13[BH]54%14[BH]6%15%16[BH]87%17[BH]9%10%18[BH]%17%15%19[BH]%14%12%16[BH]%18%11%13%19)CC.[K+]
"Potassium N,N,N-trihexylammonio-undecahydro-closo-dodecaborate",C18H39*KN,1033467-12-7,CCCCCC[N+](CCCCCC)([1*-2])CCCCCC.[K+],[1*-2][N+](CCCCCC)(CCCCCC)CCCCCC.[K+],449.42,0.19,,24,V79,WST-1,"Schaffran, 2009, Green Chem.",10.1039/b906165g,CAS for neutral compound. SMILES from SciFinder - CCCCCC[N](CCCCCC)(B1234[BH]567[BH]189[BH]2%10%11[BH]3%12%13[BH]54%14[BH]6%15%16[BH]87%17[BH]9%10%18[BH]%17%15%19[BH]%14%12%16[BH]%18%11%13%19)CCCCCC.[K+]
"Potassium N,N,N-triisopentylammonio-undecahydro-closo-dodecaborate",C15H33*KN,,CC(C)CC[N+](CCC(C)C)([1*-2])CCC(C)C.[K+],[1*-2][N+](CCC(C)C)(CCC(C)C)CCC(C)C.[K+],407.34,0.25,,24,V79,WST-1,"Schaffran, 2009, Green Chem.",10.1039/b906165g,SMILES equal to SciFinder - CCCCC[N](CCC(C)C)(B1234[BH]567[BH]189[BH]2%10%11[BH]3%12%13[BH]54%14[BH]6%15%16[BH]87%17[BH]9%10%18[BH]%17%15%19[BH]%14%12%16[BH]%18%11%13%19)CCC(C)C.[K+]
"Potassium N,N,N-trimethylammonio-undecahydro-closo-dodecaborate",C3H9*KN,1033466-88-4,C[N+](C)([1*-2])C.[K+],[1*-2][N+](C)(C)C.[K+],239.02,9.1,,24,V79,WST-1,"Schaffran, 2009, Green Chem.",10.1039/b906165g,CAS for neutral compound. SMILES from SciFinder - C[N](B1234[BH]567[BH]189[BH]2%10%11[BH]3%12%13[BH]54%14[BH]6%15%16[BH]87%17[BH]9%10%18[BH]%17%15%19[BH]%14%12%16[BH]%18%11%13%19)(C)C.[K+]
"Potassium N,N,N-tripropylammonio-undecahydro-closo-dodecaborate",C9H21*KN,1033466-97-5,CCC[N+](CCC)([1*-2])CCC.[K+],[1*-2][N+](CCC)(CCC)CCC.[K+],323.18,0.48,,24,V79,WST-1,"Schaffran, 2009, Green Chem.",10.1039/b906165g,CAS for neutral compound. SMILES from SciFinder - CCC[N](B1234[BH]567[BH]189[BH]2%10%11[BH]3%12%13[BH]54%14[BH]6%15%16[BH]87%17[BH]9%10%18[BH]%17%15%19[BH]%14%12%16[BH]%18%11%13%19)(CCC)CCC.[K+]
"Potassium N,N-diethyl-N-benzylammonio-undecahydro-closo-dodecaborate",C11H17*KN,1197209-98-5,CC[N+](CC)([1*-2])CC1=CC=CC=C1.[K+],[1*-2][N+](CC)(CC)Cc1ccccc1.[K+],343.17,0.72,,24,V79,WST-1,"Schaffran, 2009, Green Chem.",10.1039/b906165g,CAS for neutral compound. SMILES from SciFinder - CC[N](CC1=CC=CC=C1)(CC)B2345[BH]678[BH]9%102[BH]%11%123[BH]%13%144[BH]6%155[BH]%16%177[BH]%15%18%13[BH]%14%19%11[BH]%18%20%16[BH]%1798[BH]%19%20%12%10.[K+]
